Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Mesh.i » - entrée « Angiotensin-Converting Enzyme 2 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Angiotensin Receptor Antagonists < Angiotensin-Converting Enzyme 2 < Angiotensin-Converting Enzyme Inhibitors  Facettes :

List of bibliographic references indexed by Angiotensin-Converting Enzyme 2

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]
Ident.Authors (with country if any)Title
000181 (2021) Pravindra Kumar [Inde] ; Ashok Kumar Sah [Inde] ; Greesham Tripathi [Inde] ; Anjali Kashyap [Inde] ; Avantika Tripathi [Inde] ; Rashmi Rao [Inde] ; Prabhu C. Mishra [Inde] ; Koustav Mallick [Inde] ; Amjad Husain [Inde] ; Manoj Kumar Kashyap [Inde]Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
000355 (2021) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
000478 (2021) Hardeep Kaur [Inde] ; Phulen Sarma [Inde] ; Anusuya Bhattacharyya [Inde] ; Manisha Prajapat [Inde] ; Subodh Kumar [Inde] ; Ajay Prakash [Inde] ; Bikash Medhi [Inde]Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
000510 (2021) Smarajit Maiti [Inde] ; Amrita Banerjee [Inde]Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study.
000645 (2021) Riadh Badraoui [Arabie saoudite, Tunisie] ; Mohd Adnan [Arabie saoudite] ; Fevzi Bardakci [Arabie saoudite, Turquie] ; Mousa M. Alreshidi [Arabie saoudite]Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.
000652 (2021) Jia Fu [République populaire de Chine] ; Qianqian Jia [République populaire de Chine] ; Huaxin Zhou [République populaire de Chine] ; Liyang Zhang [République populaire de Chine] ; Saisai Wang [République populaire de Chine] ; Peida Liang [République populaire de Chine] ; Yanni Lv [République populaire de Chine] ; Shengli Han [République populaire de Chine]Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.
000765 (2021) Eric Duverger [France] ; Guillaume Herlem [France] ; Fabien Picaud [France]A potential solution to avoid overdose of mixed drugs in the event of Covid-19: Nanomedicine at the heart of the Covid-19 pandemic.
000952 (2020) Mario B. García-Saavedra ; Renzo R. Rosales-Gutiérrez [Pérou] ; Esmeralda Valverde [Pérou] ; Maryuri Chumbes-Aguirre [Pérou] ; Ricardo Alvarado [Pérou] ; Robert Polo [Pérou] ; Rubén Aza Ero [Pérou] ; Carlos Chávez [Pérou][Cardiovascular implications of SARS-CoV-2 infection: A literature review].
000997 (2020) Zeinab Imani-Saber [Iran] ; Hajar Vaseghi [Iran] ; Mojdeh Mahdian [Iran] ; Fatemeh Safari [Iran] ; Mohsen Ghadami [Iran]Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.
000A31 (2020) Begum Dariya [Inde] ; Ganji Purnachandra Nagaraju [États-Unis]Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients.
000A73 (2020) Yan Wang [République populaire de Chine] ; Lei Chen [États-Unis]Tissue distributions of antiviral drugs affect their capabilities of reducing viral loads in COVID-19 treatment.
000A75 (2020) Philippe Caron [France]Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management.
000B06 (2020) Rami A. Ballout [États-Unis] ; Dmitri Sviridov [Australie] ; Michael I. Bukrinsky [États-Unis] ; Alan T. Remaley [États-Unis]The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.
000B23 (2020) Kuma Diriba [Éthiopie] ; Ephrem Awulachew [Éthiopie] ; Eyob Getu [Éthiopie]The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis.
000B50 (2020) Gerardo Casucci [Italie] ; Domenico Acanfora [Italie] ; Raffaele Antonelli Incalzi [Italie]The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets.
000B83 (2020) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
000B84 (2020) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
000C32 (2020) Mateus Da Silveira Cespedes [Brésil] ; José Carlos Rosa Pires De Souza [Brésil]Sars-CoV-2: A clinical update - II.
000C53 (2020) Gisela Canedo-Marroquín [Chili] ; Farides Saavedra [Chili] ; Catalina A. Andrade [Chili] ; Roslye V. Berrios [Chili] ; Linmar Rodríguez-Guilarte [Chili] ; María C. Opazo [Chili] ; Claudia A. Riedel [Chili] ; Alexis M. Kalergis [Chili]SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
000C65 (2020) Lin Wu [République populaire de Chine] ; Aislinn M. O'Kane [États-Unis] ; Hu Peng [République populaire de Chine] ; Yaguang Bi [République populaire de Chine] ; Dagmara Motriuk-Smith [États-Unis] ; Jun Ren [États-Unis]SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.
000E06 (2020) Satya P. Gupta [Inde]Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Angiotensin-Converting Enzyme 2" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Angiotensin-Converting Enzyme 2" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Angiotensin-Converting Enzyme 2
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021